LOADING
Comparing Exxon Mobil Corporation (XOM) and Merck & Company (MRK) across the Energy and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | XOM | MRK |
|---|---|---|
| Price | $151.57 | $113.45 |
| Change Today | +0.62% | +0.96% |
| Market Cap | $628.2B | $280.2B |
| P/E Ratio | 25.6 | 32.0 |
| Forward P/E | 14.2 | 22.0 |
| PEG Ratio | 1.32 | 5.18 |
| EPS | $5.93 | $3.55 |
| Revenue Growth (YoY) | 2.6% | 4.9% |
| Profit Margin | 7.8% | 13.6% |
| Return on Equity | 9.9% | 18.9% |
| Dividend Yield | 2.68% | 2.92% |
| Beta | 0.18 | 0.20 |
| 52-Week High | $176.41 | $124.22 |
| 52-Week Low | $98.73 | $70.74 |
| Volume | 15.8M | 8.1M |
Exxon Mobil Corporation is the larger company by market capitalization. Exxon Mobil Corporation trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company offers a higher dividend yield for income investors. Merck & Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.